Tag: venous thromboembolism industry

  • 2024 Respiratory Disease Vaccine Market Outlook: Size, Share, and Key Growth Drivers

    2024 Respiratory Disease Vaccine Market Outlook: Size, Share, and Key Growth Drivers

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Respiratory Disease Vaccine Market from 2024 to 2033?

    The respiratory disease vaccine market has steadily grown. It is expected to rise from $68.4 billion in 2023 to $69.99 billion in 2024, with a CAGR of 2.3%. Factors driving this growth include the rising incidence of respiratory diseases, greater public awareness of vaccination, public health initiatives, and growing demand for effective and well-tolerated vaccines.

    The respiratory disease vaccine market will grow to $76.18 billion in 2028, at a CAGR of 2.1%. The aging population, rising healthcare expenditures, investments in vaccine development, and pandemic preparedness contribute to this growth. Trends include the development of innovative vaccines, collaborative research, advancements in vaccine development, and drug approvals.

    Claim Your Free Sample of the Global Respiratory Disease Vaccine Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12924&type=smp

    The increasing incidence of tuberculosis is expected to propel the respiratory disease vaccine market. Tuberculosis remains a global health concern, prompting efforts to develop vaccines for prevention. According to the World Health Organization, there were an estimated 10.6 million tuberculosis cases in 2021, marking a 4.5% increase from the previous year. The rising tuberculosis incidence will drive the growth of the respiratory disease vaccine market.

    1) By Type: Viral Vaccine, Bacterial Vaccine, Combination Vaccine

    2) By Infection: COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections

    3) By Age: Infant, Adolescent, Adult

    4) By End-User: Clinic, Hospital, Other End-Users

    Companies in the respiratory disease vaccine market are developing new products to improve vaccine efficacy. In May 2023, Pfizer Inc. received FDA approval for ABRYSVO, a bivalent RSV vaccine, designed to prevent lower respiratory tract disease caused by the respiratory syncytial virus in individuals aged 60 and above. The vaccine has shown high safety and efficacy in clinical trials.

    Order Now for Fast Delivery of Your Respiratory Disease Vaccine Market Report!

    https://www.thebusinessresearchcompany.com/report/respiratory-disease-vaccine-global-market-report

    North America was the largest region in the car subscription market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the car subscription market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Respiratory Disease Vaccine Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the respiratory disease vaccine market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Respiratory Disease Vaccine Market Include
    1. Respiratory Disease Vaccine Market Executive Summary
    2. Respiratory Disease Vaccine Market Segments
    3. Respiratory Disease Vaccine Market Size And Template Market Growth Rate
    4. Key Respiratory Disease Vaccine Market Trends
    5. Major Respiratory Disease Vaccine Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Respiratory Disease Vaccine Market
    26. Top Respiratory Disease Vaccine Companies
    27. Respiratory Disease Vaccine Market Opportunities And Strategies
    28. Respiratory Disease Vaccine Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:

    Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

    Respiratory Disposables Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report

    Respiratory Devices And Equipment (Diagnostic) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Insights into the Future Growth Potential of the Venous Thromboembolism Market 2024-2033

    Insights into the Future Growth Potential of the Venous Thromboembolism Market 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Venous Thromboembolism Market from 2024 to 2033?

    The venous thromboembolism market has seen steady growth in recent years, with its size increasing from $2.33 billion in 2023 to $2.44 billion in 2024, reflecting a compound annual growth rate (CAGR) of 4.8%. This growth is attributed to factors like an aging population, advancements in anticoagulants, reimbursement policies, and increased investments.

    The venous thromboembolism market is expected to grow steadily, reaching $2.87 billion by 2028, with a compound annual growth rate (CAGR) of 4.2%. Factors driving this growth include increased global healthcare access, genetic risk assessment, telemedicine, remote monitoring, and patient education. Major trends include extended thromboprophylaxis, novel oral anticoagulants, personalized treatment plans, and advanced diagnostic imaging.

    Claim Your Free Sample of the Global Venous Thromboembolism Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13001&type=smp

    The expansion of healthcare infrastructure is expected to propel the venous thromboembolism market. The healthcare industry is expanding, leading to the development of necessary policies and practices for venous thromboembolism (VTE) prevention and treatment. In May 2023, the American Health Care Association reported a rise in the number of hospitals in the US, while the Office for National Statistics in the UK noted a 9.4% increase in healthcare spending from 2020 to 2021. This growth in healthcare infrastructure supports the venous thromboembolism market.

    1) By Type: Deep Vein Thrombosis, Pulmonary Embolism, Other Types

    2) By Treatment: Anti-Clotting Medications,  Mechanical Devices, Thrombolytic Therapy, Other Treatment

    3) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users

    Major companies in the venous thromboembolism market are advancing anticoagulant drugs to improve patient care. For instance, in September 2022, Anthos Therapeutics, a US-based clinical-stage company, received FDA approval for abelacimab, an anticoagulant medicine. This fully human monoclonal antibody is designed to prevent stroke and systemic embolism in patients with atrial fibrillation, and it works by inhibiting Factor XI to offer a novel approach to anticoagulation.

    Order Now for Fast Delivery of Your Venous Thromboembolism Market Report!

    https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report

    North America was the largest region in the hemostasis products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostasis products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Venous Thromboembolism Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the venous thromboembolism market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Venous Thromboembolism Market Include

    1. Venous Thromboembolism Market Executive Summary

    2. Venous Thromboembolism Market Segments

    3. Venous Thromboembolism Market Size And Template Market Growth Rate

    4. Key Venous Thromboembolism Market Trends

    5. Major Venous Thromboembolism Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Venous Thromboembolism Market

    26. Top Venous Thromboembolism Companies

    27. Venous Thromboembolism Market Opportunities And Strategies

    28. Venous Thromboembolism Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Analysis of Blood Transfusion Diagnostics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

    Patient Blood Management Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

    Anemia and Other Blood Disorder Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: